TVARDI THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense
TVARDI THERAPEUTICS, INC. (TVRD) reported Increase (Decrease) in Prepaid Expense of $1.06 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2025-05-13
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2025-03-31 was $1.06M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2024-12-31 was -$1.85M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2024-09-30 was -$1.40M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2024-06-30 was -$2.01M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2024 was -$7.63M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2023 was -$8.11M, a 159.01% decline from fiscal 2022.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2022 was $13.75M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2021 was -$9.56M, a 397.45% decline from fiscal 2020.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.06M 10-Q · filed 2025-05-13 | -$790.00K derived: sum of 2 quarters · filed 2025-05-13 | -$2.19M derived: sum of 3 quarters · filed 2025-05-13 | -$4.20M derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$3.25M derived: sum of 2 quarters · filed 2025-03-11 | -$5.26M derived: sum of 3 quarters · filed 2025-03-11 | -$7.63M 10-K · filed 2025-03-11 |
| 2024-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$3.41M derived: sum of 2 quarters · filed 2024-11-14 | -$5.77M 10-Q · filed 2024-11-14 | -$10.28M derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-06-30 | -$2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$4.38M 10-Q · filed 2024-08-14 | -$8.88M derived: sum of 3 quarters · filed 2025-05-13 | -$11.20M derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-03-31 | -$2.36M 10-Q · filed 2025-05-13 | -$6.87M derived: sum of 2 quarters · filed 2025-05-13 | -$9.19M derived: sum of 3 quarters · filed 2025-05-13 | -$11.40M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$6.82M derived: sum of 2 quarters · filed 2025-03-11 | -$9.04M derived: sum of 3 quarters · filed 2025-03-11 | -$8.11M 10-K · filed 2025-03-11 |
| 2023-09-30 | -$2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$4.54M derived: sum of 2 quarters · filed 2024-11-14 | -$3.61M 10-Q · filed 2024-11-14 | -$5.90M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | -$2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.29M 10-Q · filed 2024-08-14 | -$3.59M derived: sum of 3 quarters · filed 2025-03-11 | $8.95M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $928.00K 10-Q · filed 2024-05-13 | -$1.37M derived: sum of 2 quarters · filed 2025-03-11 | $11.17M derived: sum of 3 quarters · filed 2025-03-11 | $12.08M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $10.24M derived: sum of 2 quarters · filed 2025-03-11 | $11.15M derived: sum of 3 quarters · filed 2025-03-11 | $13.75M 10-K · filed 2025-03-11 |
| 2022-09-30 | $12.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $13.45M derived: sum of 2 quarters · filed 2023-11-13 | $16.04M 10-Q · filed 2023-11-13 | $12.30M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $913.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $3.51M 10-Q · filed 2023-08-07 | -$232.00K derived: sum of 3 quarters · filed 2024-03-06 | -$2.27M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | $2.59M 10-Q · filed 2023-05-15 | -$1.15M derived: sum of 2 quarters · filed 2024-03-06 | -$3.18M derived: sum of 3 quarters · filed 2024-03-06 | -$7.91M derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | -$3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$5.78M derived: sum of 2 quarters · filed 2024-03-06 | -$10.50M derived: sum of 3 quarters · filed 2024-03-06 | -$9.56M 10-K · filed 2024-03-06 |
| 2021-09-30 | -$2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$6.76M derived: sum of 2 quarters · filed 2022-11-07 | -$5.82M 10-Q · filed 2022-11-07 | -$4.00M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | -$4.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$3.78M 10-Q · filed 2022-08-08 | -$1.96M derived: sum of 3 quarters · filed 2023-03-06 | -$1.83M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $942.00K 10-Q · filed 2022-05-09 | $2.76M derived: sum of 2 quarters · filed 2023-03-06 | $2.89M derived: sum of 3 quarters · filed 2023-03-06 | $2.33M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $1.95M derived: sum of 2 quarters · filed 2023-03-06 | $1.39M derived: sum of 3 quarters · filed 2023-03-06 | $3.21M 10-K · filed 2023-03-06 |
| 2020-09-30 | $130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$434.00K derived: sum of 2 quarters · filed 2021-11-08 | $1.39M 10-Q · filed 2021-11-08 | $1.70M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.26M 10-Q · filed 2021-08-09 | $1.57M derived: sum of 3 quarters · filed 2022-03-01 | $2.71M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.82M 10-Q · filed 2021-05-10 | $2.13M derived: sum of 2 quarters · filed 2022-03-01 | $3.27M derived: sum of 3 quarters · filed 2022-03-01 | $3.31M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.45M derived: sum of 2 quarters · filed 2022-03-01 | $1.48M derived: sum of 3 quarters · filed 2022-03-01 | $4.06M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.18M derived: sum of 2 quarters · filed 2020-11-09 | $3.75M 10-Q · filed 2020-11-09 | $4.34M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.61M 10-Q · filed 2020-08-10 | $3.20M derived: sum of 3 quarters · filed 2021-02-25 | $1.80M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.57M 10-Q · filed 2020-05-11 | $3.16M derived: sum of 2 quarters · filed 2021-02-25 | $1.76M derived: sum of 3 quarters · filed 2021-02-25 | $3.95M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$810.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.37M derived: sum of 3 quarters · filed 2021-02-25 | $3.17M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $787.00K derived: sum of 2 quarters · filed 2019-11-05 | $2.58M 10-Q · filed 2019-11-05 | $2.73M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $3.98M 10-Q · filed 2019-08-07 | $4.12M derived: sum of 3 quarters · filed 2020-02-27 | $3.68M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $1.80M 10-Q · filed 2019-05-07 | $1.94M derived: sum of 2 quarters · filed 2020-02-27 | $1.50M derived: sum of 3 quarters · filed 2020-02-27 | $1.45M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$300.00K derived: sum of 2 quarters · filed 2020-02-27 | -$344.00K derived: sum of 3 quarters · filed 2020-02-27 | $105.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | -$443.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$487.00K derived: sum of 2 quarters · filed 2018-11-06 | -$38.00K 10-Q · filed 2018-11-06 | -$3.33M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $405.00K 10-Q · filed 2018-08-07 | -$2.88M derived: sum of 3 quarters · filed 2019-03-12 | -$1.46M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $449.00K 10-Q · filed 2018-05-09 | -$2.84M derived: sum of 2 quarters · filed 2019-03-12 | -$1.42M derived: sum of 3 quarters · filed 2019-03-12 | -$594.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$1.87M derived: sum of 2 quarters · filed 2019-03-12 | -$1.04M derived: sum of 3 quarters · filed 2019-03-12 | -$199.00K 10-K · filed 2019-03-12 |
| 2016-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $2.25M derived: sum of 2 quarters · filed 2017-11-02 | $3.09M 10-Q · filed 2017-11-02 | $2.88M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $825.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.67M 10-Q · filed 2017-08-03 | $1.46M derived: sum of 3 quarters · filed 2018-03-15 | $2.81M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $844.00K 10-Q · filed 2017-05-04 | $637.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.98M derived: sum of 3 quarters · filed 2018-03-15 | $1.55M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | -$207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.14M derived: sum of 2 quarters · filed 2018-03-15 | $709.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.44M 10-K · filed 2018-03-15 |
| 2015-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $916.00K derived: sum of 2 quarters · filed 2016-11-04 | $1.65M 10-Q · filed 2016-11-04 | $1.50M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | -$430.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $303.00K 10-Q · filed 2016-08-04 | $155.00K derived: sum of 3 quarters · filed 2017-03-10 | |
| 2015-03-31 | $733.00K 10-Q · filed 2016-05-05 | $585.00K derived: sum of 2 quarters · filed 2017-03-10 | ||
| 2014-12-31 | -$148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$388.00K 10-K · filed 2017-03-10 | ||
| 2014-09-30 | -$240.00K 10-Q · filed 2015-11-09 | |||
| 2014-03-31 | $377.00K 10-Q · filed 2015-05-12 | $1.99M derived: sum of 2 quarters · filed 2016-03-11 | ||
| 2013-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $1.74M 10-K · filed 2016-03-11 | ||
| 2013-09-30 | $128.00K 10-Q · filed 2014-11-10 | |||
| 2012-12-31 | -$73.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |